As of Feb 21, 2025, the Staar Surgical stock's PE ratio is 38.34. This results from the current EPS of $0.44 and stock price of $16.87. The P/E ratio has decreased by 63% from the past four quarters average of 103.8.
The PE ratio of Staar Surgical has averaged 232.25 over the last seven years. The current PE ratio of 38.34 is 83% below the historical average. In the past seven years, STAA's PE ratio was at its highest in the Mar 2018 quarter at 740, when the stock price was $14.8 and the EPS was $0.02. The lowest value was in the Dec 2022 quarter, when it reached 58.48 with a price of $48.54 and an EPS of $0.83.
Maximum annual increase: 467.18% in 2021
Maximum annual decrease: -74.17% in 2021
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | 70.93 | 21.29% | $31.21 | $0.44 |
2022 | 58.48 | -62.85% | $48.54 | $0.83 |
2021 | 157.41 | -74.17% | $91.3 | $0.58 |
2021 | 609.38 | 467.18% | $79.22 | $0.13 |
2020 | 107.44 | -58.76% | $34.38 | $0.32 |
2018 | 260.5 | N/A | $31.26 | $0.12 |
2017 | N/A | N/A | $15.5 | -$0.05 |
2016 | N/A | N/A | $10.85 | -$0.3 |
2016 | N/A | N/A | $7.14 | -$0.17 |
2015 | N/A | N/A | $9.03 | -$0.22 |
2014 | 1,610 | N/A | $16.1 | $0.01 |
2012 | N/A | N/A | $5.82 | -$0.05 |
2011 | 262.25 | N/A | $10.49 | $0.04 |
2010 | N/A | N/A | $6.1 | $0 |
2010 | N/A | N/A | $3.1 | -$0.19 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 84.61 | -39.58% | $37.23 | $0.44 |
Jun 2024 | 140.03 | 17.05% | $47.61 | $0.34 |
Mar 2024 | 119.63 | 68.66% | $38.28 | $0.32 |
Dec 2023 | 70.93 | -24.09% | $31.21 | $0.44 |
Sep 2023 | 93.44 | -4.02% | $40.18 | $0.43 |
Jun 2023 | 97.35 | 3.52% | $52.57 | $0.54 |
Mar 2023 | 94.04 | 60.81% | $63.95 | $0.68 |
Dec 2022 | 58.48 | -30.37% | $48.54 | $0.83 |
Sep 2022 | 83.99 | -11.58% | $70.55 | $0.84 |
Jul 2022 | 94.99 | -20.92% | $72.19 | $0.76 |
Apr 2022 | 120.12 | -23.69% | $80.48 | $0.67 |
Dec 2021 | 157.41 | -39.64% | $91.3 | $0.58 |
Oct 2021 | 260.8 | -20.71% | $127.79 | $0.49 |
Jul 2021 | 328.93 | -28.47% | $144.73 | $0.44 |
Apr 2021 | 459.83 | -24.54% | $105.76 | $0.23 |
The current PE ratio of STAA is lower than the 3, 5 and 10-year averages.
Compared to its peers ABT and COO, STAA's PE ratio stands lower, however it is higher than NVS's.
Stock name | PE ratio | Market cap |
---|---|---|
NVS Novartis AG | 18.47 | $215.98B |
STAA Staar Surgical Co | 38.34 | $831.28M |
ABT Abbott Laboratories | 40.88 | $234.01B |
COO Cooper Companies Inc | 44.91 | $17.66B |
IRIX Iridex Corp | N/A | $25.04M |
The price to earnings ratio for STAA stock is 38.34 as of Feb 21, 2025.
The 3-year average PE ratio for STAA stock is 96.15.
The 5-year average PE ratio for STAA stock is 190.48.
The highest quarterly PE ratio in the last seven years has been 740 and it was in the Mar 2018 quarter.
STAA's price to earnings ratio is currently 83% below its 7-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Feb 21, 2025), Staar Surgical's stock price is $16.87. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.44. Therefore, Staar Surgical's P/E ratio for today is 38.34. PE RATIO(38.34) = STOCK PRICE($16.87) / TTM EPS($0.44)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.